Prosthesis survivorship and clinical outcome of the Austin Moore hemiarthroplasty: An 8-year mean follow-up of a consecutive series of 500 patients.
The results of a consecutive series of 500 patients treated with Austin Moore hemiarthroplasty prosthesis are reported. The range of follow-up was from 5-12 years and the mean was 8 years. Only 10 patients were lost to follow-up and 398 (81%) patients died within the follow-up period. The mean age of the patient population was 82 years, and 85% were women. The cumulative survivorship of the prosthesis was calculated at 94% (95% CI 90-96%) at 5 years and 83% (95% CI 65-94%) at 12 years. A total of 66 secondary operations of any type were required in 46 (9%) patients. Revision of the Austin Moore prosthesis was performed in 23 cases (5%). Of the long-term survivors contacted for follow-up, 66 (81%) had no pain or minimal pain, whilst 5 (6%) reported constant pain in the hip. The revision rates in our series were higher for younger patients, those from their own home and with good pre-fracture mobility and mental function. For the frail elderly with a displaced intracapsular fracture this prosthesis can still be recommended. This paper presents the largest consecutive series, with the longest follow-up, currently available.
Norrish
Alan R
AR
Beit Trust CURE International Hospital, P.O. Box 31236, Blantyre 3, Malawi. arnorrish@yahoo.co.uk
Rao
Janardhan
J
Parker
Martyn J
MJ
D000368:Aged; D000369:Aged, 80 and over; D019644:Arthroplasty, Replacement, Hip; D005260:Female; D005500:Follow-Up Studies; D006620:Hip Fractures / Q000601:surgery*; D006622:Hip Prosthesis; D006801:Humans; D008297:Male; D008875:Middle Aged; D011474:Prosthesis Design; D011475:Prosthesis Failure; D012086:Reoperation; D013997:Time Factors; D016896:Treatment Outcome